Clinical Trial Update: Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating blood glucose during infusion with HepaGam B in hepatitis B patients after liver transplant. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HepaGam B (hepatitis B immune globulin)

Snippet

Sponsor: Georgetown University | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2015-09-28